Efficacy and safety of cabozantinib rechallenge in metastatic renal cell carcinoma: A retrospective multicentric study.
Eur J Cancer
; 193: 113292, 2023 Nov.
Article
in En
| MEDLINE
| ID: mdl-37717282
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Clinical_trials
/
Observational_studies
Language:
En
Journal:
Eur J Cancer
Year:
2023
Document type:
Article
Affiliation country:
France
Country of publication:
United kingdom